{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:41:26Z","timestamp":1760146886979,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Youth Foundation of the Zhongshan Hospital of Fudan University","award":["No.2021ZSQN19"],"award-info":[{"award-number":["No.2021ZSQN19"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Objective: Postoperative nausea and vomiting (PONV) was one of the common complications in patients with HCC who had undergone TACE. This study was a prospective analysis of patient data to investigate risk factors for PONV in patients after TACE. Material and Methods: Data were collected from 212 patients undergoing TACE in the interventional department between August 2022 and August 2023. Including: gender, age, education, BMI, operation time, concomitant underlying diseases and drugs, preoperative limosis, history of nausea and vomiting, history of kinetosis, history of smoking or drinking, and occurrence of PONV. A visual analog scale was used to measured pain. Neuropsychological status was also assessed, using the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7) and the Patient Health Questionnaire-9(PHQ-9). To identify risk factors for PONV, multiple logistic regression analysis was used. The receiver operating characteristic (ROC) curve was plotted to assess the regression model. The clinical trial number did not apply in the study. Results: In this study, 212 out of a total of 904 patients with HCC undergoing TACE during their hospital stay were included for analysis. Among the included patients, the incidence of PONV was as high as 42% (89\/212). Multiple logistic regression analysis showed that chronic gastritis (odds ratio [OR] = 10.350; p = 0.020), VAS (OR = 3.835; p = 0.003), epirubicin (OR = 26.685; p &lt; 0.001), and the dosage of lipiodol (\u22655 mL) (OR = 1.385; p &lt; 0.001) were independent risk factors of PONV after TACE. The ROC curve demonstrated that the AUC was 0.902, the sensitivity was 84.3%, and the specificity was 87%. Conclusions: PONV is highly prevalent among patients with HCC after TACE. Chronic gastritis, pain, epirubicin, and the dosage of lipiodol were independent risk factors for PONV. The risk prediction model that was constructed according to the aforementioned factors demonstrated good discriminatory capacity for predicting the risk of post-TACE PONV, which can improve the recognition of medical providers, and has a good ability to prevent and treat nausea and vomiting.<\/jats:p>","DOI":"10.3390\/curroncol32010017","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T07:34:19Z","timestamp":1735630459000},"page":"17","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors for Postoperative Nausea and Vomiting After TACE: A Prospective Cohort Study"],"prefix":"10.3390","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-8980","authenticated-orcid":false,"given":"Yuzhu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Zhongshan Hospital, Fudan University, Shanghai 200032, China"},{"name":"National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Institution of Medical Imaging, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Zhongshan Hospital, Fudan University, Shanghai 200032, China"},{"name":"National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Institution of Medical Imaging, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianzhou","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Interventional Therapy, Zhongshan Hospital, Fudan University, Shanghai 200032, China"},{"name":"National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China"},{"name":"Shanghai Institution of Medical Imaging, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: A 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"ref_3","first-page":"1228","article-title":"Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma","volume":"17","author":"Tang","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/NCC.0000000000000302","article-title":"Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer","volume":"39","author":"Blackburn","year":"2016","journal-title":"Cancer Nurs."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4103\/jcrt.jcrt_132_21","article-title":"Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization","volume":"17","author":"He","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/00365520801971744","article-title":"Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence and risk factor analysis","volume":"43","author":"Li","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s00268-015-3386-9","article-title":"Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases","volume":"40","author":"Bhutiani","year":"2016","journal-title":"World J. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","article-title":"Determinants of postembolization syndrome after hepatic chemoembolization","volume":"12","author":"Leung","year":"2001","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jfma.2022.04.018","article-title":"Reliability and validity of the traditional Chinese version of the GAD-7 in Taiwanese patients with epilepsy","volume":"121","author":"Shih","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2340\/00015555-1265","article-title":"Visual analogue scale: Evaluation of the instrument for the assessment of pruritus","volume":"92","author":"Reich","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_12","first-page":"e924911","article-title":"Construction of a risk prediction model for fever after painless bronchoscopy","volume":"26","author":"Lv","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2013.10.037","article-title":"Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting","volume":"722","author":"Horn","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MCG.0000000000001164","article-title":"Practical Perspectives in the Treatment of Nausea and Vomiting","volume":"53","author":"Cangemi","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lu, H., Zheng, C., Liang, B., and Xiong, B. (2021). Mechanism and risk factors of nausea and vomiting after TACE: A retrospective analysis. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08253-1"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.7314\/APJCP.2013.14.10.5995","article-title":"Nausea and Vomiting after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Incidence and Risk Factor Analysis","volume":"14","author":"Wang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jopan.2019.03.007","article-title":"Pharmacogenetics of postoperative nausea and vomiting","volume":"34","author":"Aroke","year":"2019","journal-title":"J. Perianesth. Nurs."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Du, Y., Bai, Y., Xie, P., Fang, J., Wang, X., Hou, X., Tian, D., Wang, C., Liu, Y., and Sha, W. (2014). Chronic gastritis in China: A national multi-center survey. BMC Gastroenterol., 14.","DOI":"10.1186\/1471-230X-14-21"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jopan.2016.02.012","article-title":"Factors affecting postoperative nausea and vomiting in surgical patients","volume":"33","author":"Son","year":"2018","journal-title":"J. Perianesth. Nurs."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.6004\/jnccn.2017.0117","article-title":"NCCN Guidelines Insights: Antiemesis, Version 2.2017","volume":"15","author":"Berger","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.11606\/s1518-8787.2020054002178","article-title":"Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting","volume":"54","author":"Simino","year":"2020","journal-title":"Rev. Saude Publica"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/ija.IJA_16_20","article-title":"Retrospective analysis of risk factors of postoperative nausea and vomiting in patients undergoing ambulatory strabismus surgery via general anaesthesia","volume":"64","author":"Li","year":"2020","journal-title":"Indian J. Anaesth."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00520-019-05178-1","article-title":"Effect of palonosetron and dexamethasone administration on the prevention of gastrointestinal symptoms in hepatic arterial chemoembolization with epirubicin","volume":"28","author":"Sakamoto","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1177\/0300060519835700","article-title":"Effect of multimodal intervention on postoperative nausea and vomiting in patients undergoing gynecological laparoscopy","volume":"47","author":"Ma","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"ref_25","first-page":"197","article-title":"Impact of preventive administration of antiemetic drugs on risk of acute nausea and vomiting induced by transcatheter arterial chemoembolization in patients with hepatocellular carcinomas\u2014A retrospective study","volume":"40","author":"Kabuki","year":"2013","journal-title":"Gan Kagaku Ryoho"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2174\/1573405615666181122145330","article-title":"Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization","volume":"15","author":"Arslan","year":"2019","journal-title":"Curr. Med. Imaging Rev."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/1\/17\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:27Z","timestamp":1760115327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/1\/17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["curroncol32010017"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32010017","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2024,12,28]]}}}